← All Lists
symptoms · 7 items · 1 min read

7 Reasons Psoriasis Gets Worse During Menopause (And What the Evidence Says)

Rose
A note from Rose

So many women describe the same thing: psoriasis they had under control for a decade suddenly flaring badly in their mid-to-late forties, right when everything else starts shifting too. The cruelest part is that the two things — the skin and the hormones — rarely get discussed in the same room. If this is happening to you, you are not imagining the connection. The biology is real and it matters.

Learn more about Rose →
For women who have managed psoriasis for years, perimenopause can feel like the rug being pulled out — flares become more frequent, harder to control, and seemingly disconnected from old triggers. What's rarely explained is that estrogen is a powerful immune regulator, and when levels begin their erratic decline, the inflammatory pathways that drive psoriasis lose a key moderating force. Dermatologists and menopause specialists almost never coordinate care on this, which leaves a lot of women confused and undertreated.
1

Estrogen Has Been Actively Suppressing Inflammation for Decades

Estrogen binds to receptors on immune cells — including T-helper cells and dendritic cells — and exerts a broadly anti-inflammatory effect that dampens the hyperactive immune signalling at the root of psoriasis. When estrogen levels fall during perimenopause, that moderating influence is withdrawn, and the Th17 and Th1 immune pathways that drive psoriatic plaques can operate with less restraint. This is not a side effect or coincidence — it is a direct physiological consequence of hormonal change.

Grade A — Strong evidence
2

Cortisol Dysregulation Adds Fuel to the Inflammatory Fire

Perimenopause disrupts the HPA axis — the stress-response system — making cortisol levels more erratic and harder to regulate. Since cortisol normally helps suppress inflammation in short bursts, chronic dysregulation means the skin's immune environment stays in a more pro-inflammatory state for longer. Women already prone to psoriasis face a compounding effect: hormonal volatility raises baseline stress physiology, which in turn lowers the threshold for a flare.

Grade B — Moderate evidence
3

Sleep Disruption Removes a Critical Skin Repair Window

The skin undergoes significant repair and immune recalibration during deep sleep, and psoriasis activity is closely tied to sleep quality — poor sleep increases levels of pro-inflammatory cytokines including IL-6 and TNF-alpha, both of which are elevated in psoriatic plaques. Menopause-related insomnia, driven by night sweats and estrogen-related changes to sleep architecture, systematically shortens and fragments this repair window. Research consistently shows a bidirectional relationship: psoriasis disrupts sleep, and sleep loss worsens psoriasis.

Grade A — Strong evidence
4

The Skin Barrier Itself Weakens as Estrogen Falls

Estrogen directly stimulates the production of hyaluronic acid, collagen, and ceramides — all structural components that keep the skin barrier intact and moisture-retentive. As estrogen withdraws, skin becomes thinner, drier, and more permeable, which is a known trigger for psoriatic flares in barrier-compromised skin. A weakened skin barrier also allows environmental antigens easier access to immune cells in the dermis, potentially amplifying the immune response that drives plaque formation.

Grade B — Moderate evidence
5

Progesterone Loss Shifts the Immune Balance Toward Inflammation

Progesterone, which drops sharply in perimenopause — often before estrogen does — has its own immunomodulatory role, particularly in promoting Th2 immune responses which counterbalance the Th1 and Th17 activity central to psoriasis. The loss of this balance means the immune environment tilts further toward the inflammatory phenotype that characterises active plaques. This is an underexplored piece of the puzzle, partly because progesterone's skin-specific immune effects have received far less research funding than estrogen's.

Grade B — Moderate evidence
6

Weight Gain Around the Abdomen Increases Systemic Inflammation

Visceral adipose tissue — the fat that accumulates around the abdomen during menopause — is metabolically active and secretes pro-inflammatory adipokines including leptin and resistin, which have been directly linked to increased psoriasis severity and reduced treatment response. Studies have found that BMI and waist circumference correlate with psoriasis area and severity index (PASI) scores, and that weight loss can meaningfully reduce plaque activity. The menopausal shift in fat distribution is not cosmetic — it has real consequences for inflammatory conditions.

Grade A — Strong evidence
7

HRT May Actually Help — But Almost No One Is Discussing It

Several observational studies have found that women using hormone replacement therapy report fewer psoriasis flares and better overall skin condition during and after menopause, which is biologically consistent with estrogen's anti-inflammatory role. This does not mean HRT is a psoriasis treatment — it is not licensed as one — but for women who are already candidates for HRT based on other menopause symptoms, the potential skin benefit is a legitimate consideration worth raising with both a menopause specialist and a dermatologist. The fact that these two specialties so rarely communicate is one of the biggest gaps in care for perimenopausal women with inflammatory skin conditions.

Grade B — Moderate evidence

Want to go deeper?

Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.

Rose
Meet Rose

Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.

Sharing is caring 💕 If this list helped you feel a little less alone, consider passing Rose along to a friend who might need honest answers too.